⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Treatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in Children

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Treatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in Children

Official Title: Treatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in

Study ID: NCT06099366

Study Description

Brief Summary: Aim of this study is to investigate the outcome of NGS MRD based risk stratified treatment for standard risk acute lymphoblastic leukemia in children and adolescents.

Detailed Description:

Keywords

Eligibility

Minimum Age: 1 Year

Eligible Ages: CHILD

Sex: ALL

Healthy Volunteers: No

Locations

Asan Medical Center, Seoul, Other (Non U.s.), Korea, Republic of

Samsung Medical Center, Seoul, Other (Non U.s.), Korea, Republic of

Contact Details

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: